Medicare and Medicaid programs that serve the most-vulnerable Americans facing SDOH barriers can be major facilitators of appropriate non-emergency transportation to non-medical sites. But how do we determine what is appropriate, and what do we know about transportation services to non-medical sites today?
Read More
Briana Contreras, editor of Managed Healthcare Executive spoke with Luis Mosquera, CEO of Health Network One, a provider of specialty benefit management services for health insurers, in this week's episode. In this discussion, Luis and Briana talked about how value-driven decisions in a more value-based market can not only better manage costs for health plans, but create a plan of care to best meet patient’s needs. In order to do this, Luis strongly encouraged healthcare executives to experience alternative payment models and shared what payers should check off their list with a new model.
Listen
Dismantling Stigmas: How to Stop the Blame Game and Get Patients the Care they Need
February 10th 2022There is a bias in this country against people whose medical condition is perceived to be “their fault”– in other words, the result of their own lifestyle choices. To combat stigma and its harmful effects, there needs to be broader understanding, even among medical professionals.
Read More
No Giving It Short Shrift: COVID-19 Can Be a Long Haul
February 9th 2022“Long COVID” is more likely to affect older people and those who have been hospitalized, but younger people with milder symptoms are not immune to lingering symptoms. One plausible explanation is that the infection results in the activation of autoantibodies.
Read More
Study Finding: Discontinuation of Natalizumab for Pregnancy Carries Risk of Disability
February 3rd 2022German research team finds that 11% of those who quit the drug for pregnancy had “clinically meaningful disability” one-year postpartum. They don’t advise against quitting the drug but say their findings suggest that patients should be informed of the risk.
Read More
Study of a Tremelimumab-Imfinzi Combination May Lead to New Liver Cancer Treatment Strategy
February 2nd 2022Results of an AstraZeneca trial presented at a recent ASCO meeting sow hopes for a new treatment for patients diagnosed with unresectable hepatocellular carcinoma, the most common type of liver cancer.
Read More